Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 2/20 | 0.54 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.54 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.47 |
| ▸ | PPARG | P37231 | 1/20 | 0.46 |
| ▸ | PPARD | Q03181 | 1/20 | 0.46 |
| ▸ | PPARA | Q07869 | 1/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.45 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.45 |
| ▸ | RGS12 | O14924 | 1/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30801376 | 1.00 | SLC6A2 (0.54) | SLC6A2SLC6A4SLC6A3KDM4EALDH1A1 | |
| Bicarbonate SCHEMBL27926290 | 0.93 | SLC6A2 (0.48) | SLC6A2SLC6A4SLC6A3KDM4EALDH1A1 | |
| SCHEMBL551822 | 0.91 | AOC3 (0.48) | SLC6A2SLC6A4SLC6A3KDM4EALDH1A1 | |
| SCHEMBL550790 | 0.91 | AOC3 (0.48) | SLC6A2SLC6A4SLC6A3KDM4EALDH1A1 | |
| SCHEMBL3389900 | 0.91 | AOC3 (0.48) | SLC6A2SLC6A4SLC6A3KDM4EALDH1A1 | |
| SCHEMBL550791 | 0.91 | AOC3 (0.48) | SLC6A2SLC6A4SLC6A3KDM4EALDH1A1 | |
| SCHEMBL5873439 | 0.87 | TDP1 (0.50) | SLC6A2SLC6A4SLC6A3KDM4EALDH1A1 | |
| SCHEMBL4077892 | 0.87 | TDP1 (0.50) | SLC6A2SLC6A4SLC6A3KDM4EALDH1A1 | |
| SCHEMBL27825950 | 0.87 | TDP1 (0.50) | SLC6A2SLC6A4SLC6A3KDM4EALDH1A1 | |
| SCHEMBL10777899 | 0.85 | SLC6A2 (0.55) | SLC6A2SLC6A4SLC6A3KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 509 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3367821-B1 | METHOD FOR PREPARING AN ENCAPSULATE COMPOSITION FOR USE IN AN EDIBLE COMPOSITION | INTERCONTINENTAL GREAT BRANDS LLC (US) | 2025-08-27 | — | — | EP | claimed |
| CN-115191433-A | Application of functional additive in cockroach killing composition, cockroach killing composition and application of cockroach killing composition | 中国人民解放军海军特色医学中心 | 2022-10-18 | — | — | CN | claimed |
| CN-114753155-A | Weather-resistant polyester POY oil agent | 浙江传化化学品有限公司 | 2022-07-15 | — | — | CN | claimed |
| EP-4712785-A1 | CHEWABLE COMPOSITIONS COMPRISING PECTIN AND UROLITHIN | Amazentis SA (CH) | 2026-03-25 | — | — | EP | disclosed |
| US-12576064-B2 | Urolithin gummy (pectin) formulations | AMAZENTIS SA (CH) | 2026-03-17 | — | — | US | disclosed |
| US-20260034059-A1 | ORAL FILM COMPOSITIONS AND DOSAGE FORMS HAVING PRECISE ACTIVE DISSOLUTION PROFILES | AQUESTIVE THERAPEUTICS, INC. (US) | 2026-02-05 | — | — | US | disclosed |
| US-20260014136-A1 | LIPOPHILIC ACTIVE ORAL FILM FORMULATION AND METHOD OF MAKING THE SAME | INTELGENX CORP (CA) | 2026-01-15 | — | — | US | disclosed |
| EP-4673102-A1 | TOOTH WHITENING CHEWING GUM; AND METHODS OF MAKING THE SAME | Perfetti Van Melle Benelux B.V. (NL) | 2026-01-07 | — | — | EP | disclosed |
| US-20250381253-A1 | MUTANASES AND ORAL CARE COMPOSITIONS COMPRISING SAME | NOVOZYMES A/S (DK) | 2025-12-18 | — | — | US | disclosed |
| US-20250375412-A1 | UROLITHIN GUMMY (PECTIN) FORMULATIONS | AMAZENTIS SA (CH) | 2025-12-11 | — | — | US | disclosed |
| US-20250367159-A1 | UROLITHIN GUMMY (PECTIN) FORMULATIONS | AMAZENTIS SA (CH) | 2025-12-04 | — | — | US | disclosed |
| EP-0051678-A1 | PROCESS FOR PRODUCING SPHERICAL AND POROUS VINYL RESIN PARTICLES. | GOODRICH CO B F (US) | 1982-05-19 | — | — | EP | disclosed |
| US-4308408-A | Process for the hydroxylation of styrene and styrene derivatives | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1981-12-29 | — | — | US | disclosed |
| WO-1981003333-A1 | PROCESS FOR PRODUCING SPHERICAL AND POROUS VINYL RESIN PARTICLES | GOODRICH CO B F (US) | 1981-11-26 | — | — | WO | disclosed |
| EP-0025892-A1 | Process for the hydroxylation of styrene and of styrene derivatives | Degussa Aktiengesellschaft (DE) | 1981-04-01 | — | — | EP | disclosed |
| EP-0025445-A1 | METHOD OF PREPARING SPHERICAL POROUS BEAD-TYPE POLYMERS | The B.F. GOODRICH Company (US) | 1981-03-25 | — | — | EP | disclosed |
| EP-0025445-A4 | METHOD OF PREPARING SPHERICAL POROUS BEAD-TYPE POLYMERS. | GOODRICH CO B F (US) | 1981-02-25 | — | — | EP | disclosed |
| US-4229547-A | OF HIGH BULK DENSITY POLYMERIZED AS DROPLETS SUSPENDED IN AN AQUEOUS MUCILAGE HAVING PLASTIC FLOW PROPERTIES | THE B. F. GOODRICH COMPANY (US) | 1980-10-21 | — | — | US | disclosed |
| WO-1980002029-A1 | METHOD OF PREPARING SPHERICAL POROUS BEAD-TYPE POLYMERS | GOODRICH CO B F (US) | 1980-10-02 | — | — | WO | disclosed |
| US-3990180-A | Peat containers for the planting of containerized seedlings | BUNTING WILLIAM M | 1976-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12576064-B2 | Urolithin gummy (pectin) formulations | PYGM, HAGH, GYS1 | SLC6A2 1706/4885SLC6A4 1811/4885SLC6A3 1171/4885 |
| US-20250375412-A1 | UROLITHIN GUMMY (PECTIN) FORMULATIONS | PYGM, GALE, GYS1 | SLC6A2 4454/4885SLC6A4 4587/4885SLC6A3 3993/4885 |
| US-20250367159-A1 | UROLITHIN GUMMY (PECTIN) FORMULATIONS | PYGM, GALE, GYS1 | SLC6A2 4454/4885SLC6A4 4587/4885SLC6A3 3993/4885 |
| US-20260034059-A1 | ORAL FILM COMPOSITIONS AND DOSAGE FORMS HAVING PRECISE ACTIVE DISSOLUTION PROFILES | SORD, SLC6A13, CACNA1A | SLC6A2 286/4885SLC6A4 120/4885SLC6A3 291/4885 |
| US-20260014136-A1 | LIPOPHILIC ACTIVE ORAL FILM FORMULATION AND METHOD OF MAKING THE SAME | MGLL, NPC1L1, LIPA | SLC6A2 1076/4885SLC6A4 1270/4885SLC6A3 1567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.